...
首页> 外文期刊>Protein & Cell >miR-27b inhibits gastric cancer metastasis by targeting NR2F2
【24h】

miR-27b inhibits gastric cancer metastasis by targeting NR2F2

机译:miR-27b通过靶向NR2F2抑制胃癌转移

获取原文

摘要

Increasing attention is focused on the down-regulation of miRNAs in cancer process. Nuclear receptor subfamily 2 (NR2F2, also known as COUP-TFII) is involved in the development of many types of cancers, but its role in gastric cancer remains elusive. In this experiment, oncomine and Kaplan-meier database revealed that NR2F2 was up-regulated in gastric cancer and that the high NR2F2 expression contributed to poor survival. MicroRNA-27b was targeted and down-regulated by NR2F2 in human gastric cancer tissues and cells. The ectopic expression of miR-27b inhibited gastric cancer cell proliferation and tumor growth in vitro and in vivo . Assays suggested that the overexpression of miR-27b could promote MGC-803 cells’ migration and invasion and retard their metastasis to the liver. In addition, down-regulation of miR-27b enhanced GES-1 cells’ proliferation and metastasis in vitro . These findings reveal that miR-27b is a tumor suppressor in gastric cancer and a biomarker for improving patients’ survival.
机译:越来越多的注意力集中在癌症过程中miRNA的下调。核受体亚家族2(NR2F2,也称为COUP-TFII)参与了许多类型癌症的发展,但其在胃癌中的作用仍然难以捉摸。在此实验中,oncomine和Kaplan-meier数据库显示NR2F2在胃癌中被上调,而NR2F2的高表达导致生存期差。 MicroRNA-27b在人胃癌组织和细胞中被NR2F2靶向并下调。 miR-27b的异位表达在体内外均抑制胃癌细胞增殖和肿瘤生长。研究表明,miR-27b的过表达可能促进MGC-803细胞的迁移和侵袭,并阻止其向肝转移。此外,miR-27b的下调增强了GES-1细胞的体外增殖和转移能力。这些发现表明,miR-27b是胃癌的抑癌药,也是改善患者生存率的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号